- Report
- October 2025
- 140 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- January 2026
- 182 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 198 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 196 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 191 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 193 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 194 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 191 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 183 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 189 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 199 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 198 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 198 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 195 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 180 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- March 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- March 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- October 2025
- 140 Pages
Global
From €3500EUR$4,281USD£3,144GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more